Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Human TLR8 senses UR/URR motifs in bacterial and mitochondrial RNA

Open access

Abstract

Toll-like receptor (TLR) 13 and TLR2 are the major sensors of Gram-positive bacteria in mice. TLR13 recognizes Sa19, a specific 23S ribosomal (r) RNA-derived fragment and bacterial modification of Sa19 ablates binding to TLR13, and to antibiotics such as erythromycin. Similarly, RNase A-treated Staphylococcus aureus activate human peripheral blood mononuclear cells (PBMCs) only via TLR2, implying single-stranded (ss) RNA as major stimulant. Here, we identify human TLR8 as functional TLR13 equivalent that promiscuously senses ssRNA. Accordingly, Sa19 and mitochondrial (mt) 16S rRNA sequence-derived oligoribonucleotides (ORNs) stimulate PBMCs in a MyD88-dependent manner. These ORNs, as well as S. aureus-, Escherichia coli-, and mt-RNA, also activate differentiated human monocytoid THP-1 cells, provided they express TLR8. Moreover, Unc93b1(-/-)- and Tlr8(-/-)-THP-1 cells are refractory, while endogenous and ectopically expressed TLR8 confers responsiveness in a UR/URR RNA ligand consensus motif-dependent manner. If TLR8 function is inhibited by suppression of lysosomal function, antibiotic treatment efficiently blocks bacteria-driven inflammatory responses in infected human whole blood cultures. Sepsis therapy might thus benefit from interfering with TLR8 function.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/embr.201540861

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Specific bacterial and mitochondrial ribosomal RNA segments and fractions induce proinflammatory but not type I IFN cytokine production through an endosomal TLR ACytokine release by PBMCs challenged with heat‐inactivated S. aureus (hiSa), and/or RNase A (RA)‐treated solution, or Sa19 (TLR13 activating ORN) upon TLR2 blockade (T2.5; n.p., not performed; **P ≤ 0.01; n = 3; unpaired t‐test).BAlignment of Sa19 and mitochondrial 16S rRNA Sa19 “like” segment (mt, mitochondrial; PTL, peptidyl transferase loop; D, domain; _, transition region) sequence with common core motif (blue) and uracils (red U); *conserved in human (Hs), cattle (Bt), mouse and rat; G/A underlined, mutated core motif; ma, 6N methylation of adenosine 7.CCytokine release of PBMCs transfected with ORNs including TLR7/8 ligand RNA40 (n = 3).D, EActivity of PBMCs upon bacterial RNA challenge, pretreatment with chloroquine in (D) only (S, Svedberg; r, ribosomal; tot, total; n = 3).FActivity of PBMCs upon mitochondrial (mt) RNA challenge (Hs, human; triangle, increasing doses; LFA, Lipofectamine 2000; n = 3).GActivity of PBMCs challenged with ORNs and total S. aureus (Sa) RNA (Myd88 d/d, mutant MyD88 expression not impairing LPS‐driven IL‐8 production; n = 2).HResponsiveness of undifferentiated (undiff) and 3‐ or 8‐day PMA‐differentiated (ddi) THP‐1 cells to Sa19 challenge (n = 3).IActivity of parental and Unc93b1 −/−‐3ddiTHP‐1 cells challenged with ORNs (n = 3).Data information: Graphs show mean ± SD; –, unchallenged; n.d., not detected; P3C, Pam3 CSK 4; Loxo, loxoribine.
Figure 1 Specific bacterial and mitochondrial ribosomal RNA segments and fractions induce proinflammatory but not type I IFN cytokine production through an endosomal TLR ACytokine release by PBMCs challenged with heat‐inactivated S. aureus (hiSa), and/or RNase A (RA)‐treated solution, or Sa19 (TLR13 activating ORN) upon TLR2 blockade (T2.5; n.p., not performed; **P ≤ 0.01; n = 3; unpaired t‐test).BAlignment of Sa19 and mitochondrial 16S rRNA Sa19 “like” segment (mt, mitochondrial; PTL, peptidyl transferase loop; D, domain; _, transition region) sequence with common core motif (blue) and uracils (red U); *conserved in human (Hs), cattle (Bt), mouse and rat; G/A underlined, mutated core motif; ma, 6N methylation of adenosine 7.CCytokine release of PBMCs transfected with ORNs including TLR7/8 ligand RNA40 (n = 3).D, EActivity of PBMCs upon bacterial RNA challenge, pretreatment with chloroquine in (D) only (S, Svedberg; r, ribosomal; tot, total; n = 3).FActivity of PBMCs upon mitochondrial (mt) RNA challenge (Hs, human; triangle, increasing doses; LFA, Lipofectamine 2000; n = 3).GActivity of PBMCs challenged with ORNs and total S. aureus (Sa) RNA (Myd88 d/d, mutant MyD88 expression not impairing LPS‐driven IL‐8 production; n = 2).HResponsiveness of undifferentiated (undiff) and 3‐ or 8‐day PMA‐differentiated (ddi) THP‐1 cells to Sa19 challenge (n = 3).IActivity of parental and Unc93b1 −/−‐3ddiTHP‐1 cells challenged with ORNs (n = 3).Data information: Graphs show mean ± SD; –, unchallenged; n.d., not detected; P3C, Pam3 CSK 4; Loxo, loxoribine.CC BY-NC-ND · PubMed Central
Figure EV1 Scheme of bacterial and mitochondrial (mt) largest rRNAs, Sa19 “like” segments (ORNs) within the latter, and mostly non‐responsiveness of the murine immune system to ORNs and mtRNA ASchematic of both, bacterial 23S and mitochondrial 16S rRNAs (I to VI, domains; red rectangles, Sa19 like segments within 16S mtrRNA; D, domain; PTL, peptidyl transferase loop within V).BSa19 “like” 16S rRNA segment information (abbr., abbreviation; term., terminal; *interspecies sequence conservation).CLuciferase activity (Rel. luc. act.) of transfected and challenged HEK293 cells (n = 2).DCytokine release by bone marrow‐derived macrophages (BM; LyoVec, transfection reagent; Hs, human; Rn, rat; n = 2).ESerum cytokine concentrations of mice challenged i.v. with phosphorothioate‐stabilized ORNs (n = 3).FCytokine release of splenocytes transfected with ORNs with various transfectants (pLA, poly‐L‐arginine; LFA, Lipofectamine 2000; TR, transfection reagent only; n = 2).G, H Cytokine release of challenged wild‐type (Wt) and k.o. BMs (n = 3).Data information: (C–H) Graphs show mean ± SD; –, unchallenged; n.d., not detected.
Figure EV1 Scheme of bacterial and mitochondrial (mt) largest rRNAs, Sa19 “like” segments (ORNs) within the latter, and mostly non‐responsiveness of the murine immune system to ORNs and mtRNA ASchematic of both, bacterial 23S and mitochondrial 16S rRNAs (I to VI, domains; red rectangles, Sa19 like segments within 16S mtrRNA; D, domain; PTL, peptidyl transferase loop within V).BSa19 “like” 16S rRNA segment information (abbr., abbreviation; term., terminal; *interspecies sequence conservation).CLuciferase activity (Rel. luc. act.) of transfected and challenged HEK293 cells (n = 2).DCytokine release by bone marrow‐derived macrophages (BM; LyoVec, transfection reagent; Hs, human; Rn, rat; n = 2).ESerum cytokine concentrations of mice challenged i.v. with phosphorothioate‐stabilized ORNs (n = 3).FCytokine release of splenocytes transfected with ORNs with various transfectants (pLA, poly‐L‐arginine; LFA, Lipofectamine 2000; TR, transfection reagent only; n = 2).G, H Cytokine release of challenged wild‐type (Wt) and k.o. BMs (n = 3).Data information: (C–H) Graphs show mean ± SD; –, unchallenged; n.d., not detected.CC BY-NC-ND · PubMed Central
Figure EV2 RNA subpopulation isolation, candidate mRNAs, mTLR13‐hTLR8 alignment, TLR8 mRNA knockdown, and responsiveness as well as TLR7/8 expression of differentiated k.o. THP‐1 cells A, BElectrophoresis gels of total S. aureus RNA with tRNA and 5S rRNA (left panel) or isolated 5S rRNA (right panel; PAGE) and total or purified mammalian mtRNA (agarose), respectively (kb, kilobases; M, RNA size marker; tot, total; S, Svedberg; r, ribosomal; hmw, high molecular weight; t, transfer; mt, mitochondrial RNA; sup, supernatant at initial mitochondria separation step; Rn, rat; Hs, human; *S not applicable).CReceptor mRNA amounts increased ≥ 2‐fold in 3‐day differentiated (ddi) as compared to undifferentiated (undiff) and 8ddiTHP‐1 cells, except for the data marked by a frame (depicted for comparison; dual TLR7 probe set; CLEC7A, C‐type lectin domain family 7A; FPR3, formyl peptide receptor 3; DDX58, DEAD box polypeptide; CLEC4A, C‐type lectin domain; FPR1, formyl peptide receptor; SIGLEC1, sialic acid binding Ig‐like lectin; n = 1), according to the comparative gene array‐based transcriptome profiling.DAlignment of murine (m) TLR13 and human (h) TLR8 sequences (46 residue signal and leucine‐rich repeat N‐terminal domain, LRRNT, of the latter is not depicted for clarity; dark blue, signal peptide and LRRNT; light blue, LRRs; violet, transmembrane domains; green, LRR C‐terminal and cytoplasmic Toll‐IL1 receptor resistance gene domains; orange, z‐loop; yellow and turquoise, residues known to contribute to hTLR8 ligand recognition site one and two, respectively).ERelative (Rel.) mRNA accumulation (accum.) in 3ddiTHP‐1 cells upon transfection of siRNAs (scram., scramble control; untreat., untreated; *P ≤ 0.01; unpaired t‐test; n = 3).FActivity of 3ddiTHP‐1 cells challenged with different amounts of heat‐inactivated (hi) S. aureus and E. coli (Sa and Ec, respectively; –, unchallenged; n.d., not detected; Loxo, loxoribine; P3C, Pam3 CSK 4; corresponding to Fig 3C; n = 3).GImmunoblot analysis of R848 overnight‐primed 3ddiTHP‐1 cell lysates (genotypes indicated, TLR7+ or TLR8+ HEK293 cell lysates for positive and cytoplasmic protein detection as loading controls; n = 3).Data information: Graphs show mean ± SD.
Figure EV2 RNA subpopulation isolation, candidate mRNAs, mTLR13‐hTLR8 alignment, TLR8 mRNA knockdown, and responsiveness as well as TLR7/8 expression of differentiated k.o. THP‐1 cells A, BElectrophoresis gels of total S. aureus RNA with tRNA and 5S rRNA (left panel) or isolated 5S rRNA (right panel; PAGE) and total or purified mammalian mtRNA (agarose), respectively (kb, kilobases; M, RNA size marker; tot, total; S, Svedberg; r, ribosomal; hmw, high molecular weight; t, transfer; mt, mitochondrial RNA; sup, supernatant at initial mitochondria separation step; Rn, rat; Hs, human; *S not applicable).CReceptor mRNA amounts increased ≥ 2‐fold in 3‐day differentiated (ddi) as compared to undifferentiated (undiff) and 8ddiTHP‐1 cells, except for the data marked by a frame (depicted for comparison; dual TLR7 probe set; CLEC7A, C‐type lectin domain family 7A; FPR3, formyl peptide receptor 3; DDX58, DEAD box polypeptide; CLEC4A, C‐type lectin domain; FPR1, formyl peptide receptor; SIGLEC1, sialic acid binding Ig‐like lectin; n = 1), according to the comparative gene array‐based transcriptome profiling.DAlignment of murine (m) TLR13 and human (h) TLR8 sequences (46 residue signal and leucine‐rich repeat N‐terminal domain, LRRNT, of the latter is not depicted for clarity; dark blue, signal peptide and LRRNT; light blue, LRRs; violet, transmembrane domains; green, LRR C‐terminal and cytoplasmic Toll‐IL1 receptor resistance gene domains; orange, z‐loop; yellow and turquoise, residues known to contribute to hTLR8 ligand recognition site one and two, respectively).ERelative (Rel.) mRNA accumulation (accum.) in 3ddiTHP‐1 cells upon transfection of siRNAs (scram., scramble control; untreat., untreated; *P ≤ 0.01; unpaired t‐test; n = 3).FActivity of 3ddiTHP‐1 cells challenged with different amounts of heat‐inactivated (hi) S. aureus and E. coli (Sa and Ec, respectively; –, unchallenged; n.d., not detected; Loxo, loxoribine; P3C, Pam3 CSK 4; corresponding to Fig 3C; n = 3).GImmunoblot analysis of R848 overnight‐primed 3ddiTHP‐1 cell lysates (genotypes indicated, TLR7+ or TLR8+ HEK293 cell lysates for positive and cytoplasmic protein detection as loading controls; n = 3).Data information: Graphs show mean ± SD.CC BY-NC-ND · PubMed Central
Figure 2 Transcriptome as well as gain‐ and loss‐of‐function analyses implicate TLR8 as bacteria and mitochondria ribosomal RNA sensor ACytokine release of 3‐day differentiated (ddi) THP‐1 cells toward stimulation with TLR ligands and bacterial RNAs (S, Svedberg; r, ribosomal; tot, total; n = 3).B, CResponsiveness of Unc93b1 −/−‐3ddiTHP‐1 cells treated with T2.5 and challenged with heat‐inactivated (hi) bacteria (triangle, decreasing doses; n = 3).DRatios of constitutive mRNA amounts in 3‐ versus 8ddi (gray bar) and of each of both versus undifferentiated THP‐1 cells (black or white bar, respectively) according to a transcriptome profiling result (n = 1).E, F NF‐κB‐driven relative luciferase activity (Rel. luc. act.) of hTLR8‐overexpressing HEK293 and murine RAW264.7 cells, respectively, upon challenges (vector, empty plasmid; n = 3).GTransfection of TLR8 siRNA impairs 3ddiTHP‐1 cell responsiveness (n = 3).Data information: Graphs show mean ± SD; *P ≤ 0.05; **P ≤ 0.01; unpaired t‐test; –, unchallenged; P3C, Pam3 CSK 4; n.d., not detected; Sa, S. aureus; Ec, E. coli.
Figure 2 Transcriptome as well as gain‐ and loss‐of‐function analyses implicate TLR8 as bacteria and mitochondria ribosomal RNA sensor ACytokine release of 3‐day differentiated (ddi) THP‐1 cells toward stimulation with TLR ligands and bacterial RNAs (S, Svedberg; r, ribosomal; tot, total; n = 3).B, CResponsiveness of Unc93b1 −/−‐3ddiTHP‐1 cells treated with T2.5 and challenged with heat‐inactivated (hi) bacteria (triangle, decreasing doses; n = 3).DRatios of constitutive mRNA amounts in 3‐ versus 8ddi (gray bar) and of each of both versus undifferentiated THP‐1 cells (black or white bar, respectively) according to a transcriptome profiling result (n = 1).E, F NF‐κB‐driven relative luciferase activity (Rel. luc. act.) of hTLR8‐overexpressing HEK293 and murine RAW264.7 cells, respectively, upon challenges (vector, empty plasmid; n = 3).GTransfection of TLR8 siRNA impairs 3ddiTHP‐1 cell responsiveness (n = 3).Data information: Graphs show mean ± SD; *P ≤ 0.05; **P ≤ 0.01; unpaired t‐test; –, unchallenged; P3C, Pam3 CSK 4; n.d., not detected; Sa, S. aureus; Ec, E. coli.CC BY-NC-ND · PubMed Central
Figure 3 TLR8 recognizes UR/URR motif containing RNA A, BCytokine release of 3‐day differentiated (ddi) THP‐1 cells challenged with (A) ORNs or (B) bacterial RNA fractions (tot, total; S, Svedberg; r, ribosomal).CResponsiveness of Tlr8 −/−‐3ddiTHP‐1 cells challenged with heat‐inactivated (hi) bacteria (triangle, decreasing doses; *P ≤ 0.05; **P ≤ 0.01; unpaired t‐test) upon TLR2 blockade (T2.5).DResponsiveness of 3ddiTHP‐1 cells upon challenge with human (Hs) mitochondrial (mt) RNA (triangle, increasing doses).E–H NF‐κB‐driven relative luciferase activity (Rel. luc. act.) of hTLR8+ HEK293 cells or cytokine release by PBMCs all transfected with the RNAs indicated and additional uridine (U) if indicated (n.p., not performed; vector, empty plasmid).Data information: Graphs show mean ± SD; n = 3; −, unchallenged; P3C, Pam3 CSK 4; Sa, S. aureus; Ec, E. coli; n.d., not detected.
Figure 3 TLR8 recognizes UR/URR motif containing RNA A, BCytokine release of 3‐day differentiated (ddi) THP‐1 cells challenged with (A) ORNs or (B) bacterial RNA fractions (tot, total; S, Svedberg; r, ribosomal).CResponsiveness of Tlr8 −/−‐3ddiTHP‐1 cells challenged with heat‐inactivated (hi) bacteria (triangle, decreasing doses; *P ≤ 0.05; **P ≤ 0.01; unpaired t‐test) upon TLR2 blockade (T2.5).DResponsiveness of 3ddiTHP‐1 cells upon challenge with human (Hs) mitochondrial (mt) RNA (triangle, increasing doses).E–H NF‐κB‐driven relative luciferase activity (Rel. luc. act.) of hTLR8+ HEK293 cells or cytokine release by PBMCs all transfected with the RNAs indicated and additional uridine (U) if indicated (n.p., not performed; vector, empty plasmid).Data information: Graphs show mean ± SD; n = 3; −, unchallenged; P3C, Pam3 CSK 4; Sa, S. aureus; Ec, E. coli; n.d., not detected.CC BY-NC-ND · PubMed Central
Figure EV3 TLR7 mRNA knockdown in k.o. THP‐1 cells and consequent responsiveness, Sa12 derivative sensitivity, bacterial infection‐driven type I IFN or IL‐6 production and inhibition of PBMCs or whole blood, respectively, and further species PBMC responsiveness Knockdown upon transfection of control (scramble) or two different TLR7 mRNA‐specific siRNAs (siTLR7‐1/3) in and cytokine release of respective 3‐day differentiated THP‐1 cells upon challenge (Rel., relative; accum., accumulation; Loxo, loxoribine; R848, small molecule, 50 μg/ml; tRNA, 200 ng/well of 96‐well plate E. coli transfer RNA; n = 3).Sequence alignments of Sa12 and Sa12s6U with another Sa12 variant carrying in addition, as compared to the latter, ORN and, reminiscent of the respective motif in HsmtD1, a UGA motif (blue, core sequence; red, A6U; underlined, A7G). Diagram depicts PBMC activities upon challenges with Sa12 and derivatives (n = 3). PBMC type I IFN production upon pretreatments (T2.5, TLR2‐neutralizing mAb; chloroquine, lysososmal function inhibitor) and challenge with TLR ligands or infection (5 × 104 cfu/ml; n = 2; corresponding to Fig 4B).Cytokine release of whole blood culture upon lysosome inhibition and challenge with heat‐inactivated (hi) and viable bacteria (triangle, decreasing dose of infection; n = 3; corresponding to Fig 4C).Cytokine release of Sus (S.) scrofa and Macaca (M.) mulatta PBMCs upon challenge with ORN variants (n = 3).Data information: Graphs show mean ± SD; *P ≤ 0.05; **P ≤ 0.01; unpaired t‐test; –, unchallenged; n.d., not detected; P3C, Pam3CSK4.
Figure EV3 TLR7 mRNA knockdown in k.o. THP‐1 cells and consequent responsiveness, Sa12 derivative sensitivity, bacterial infection‐driven type I IFN or IL‐6 production and inhibition of PBMCs or whole blood, respectively, and further species PBMC responsiveness Knockdown upon transfection of control (scramble) or two different TLR7 mRNA‐specific siRNAs (siTLR7‐1/3) in and cytokine release of respective 3‐day differentiated THP‐1 cells upon challenge (Rel., relative; accum., accumulation; Loxo, loxoribine; R848, small molecule, 50 μg/ml; tRNA, 200 ng/well of 96‐well plate E. coli transfer RNA; n = 3).Sequence alignments of Sa12 and Sa12s6U with another Sa12 variant carrying in addition, as compared to the latter, ORN and, reminiscent of the respective motif in HsmtD1, a UGA motif (blue, core sequence; red, A6U; underlined, A7G). Diagram depicts PBMC activities upon challenges with Sa12 and derivatives (n = 3). PBMC type I IFN production upon pretreatments (T2.5, TLR2‐neutralizing mAb; chloroquine, lysososmal function inhibitor) and challenge with TLR ligands or infection (5 × 104 cfu/ml; n = 2; corresponding to Fig 4B).Cytokine release of whole blood culture upon lysosome inhibition and challenge with heat‐inactivated (hi) and viable bacteria (triangle, decreasing dose of infection; n = 3; corresponding to Fig 4C).Cytokine release of Sus (S.) scrofa and Macaca (M.) mulatta PBMCs upon challenge with ORN variants (n = 3).Data information: Graphs show mean ± SD; *P ≤ 0.05; **P ≤ 0.01; unpaired t‐test; –, unchallenged; n.d., not detected; P3C, Pam3CSK4.CC BY-NC-ND · PubMed Central
Figure 4 Lysosomal function inhibition affecting TLR8 activity is anti‐inflammatory upon both, Gram‐positive and Gram‐negative bacterial infection ex vivo Cytokine release of 3‐day differentiated THP‐1 cells of the indicated genotypes upon TLR2 blockade (T2.5) and challenge with TLR ligands, heat‐inactivated (hi) or viable bacteria. PBMC activity upon endosome function inhibition (chloroquine) and TLR2 blockade (T2.5) followed by TLR ligand challenge or bacterial infection.Activity of whole blood culture upon endosome function inhibition (chloroquine) and challenge with TLR ligands, heat‐inactivated (hi), or viable bacteria.Data information: Graphs show mean ± SD; n = 3; *P ≤ 0.05; **P ≤ 0.01; unpaired t‐test; –, unchallenged; P3C, Pam3 CSK 4; n.d., not detected; triangles, decreasing doses of exponentially growing bacteria gentamicin‐treated 1 h post‐infection.
Figure 4 Lysosomal function inhibition affecting TLR8 activity is anti‐inflammatory upon both, Gram‐positive and Gram‐negative bacterial infection ex vivo Cytokine release of 3‐day differentiated THP‐1 cells of the indicated genotypes upon TLR2 blockade (T2.5) and challenge with TLR ligands, heat‐inactivated (hi) or viable bacteria. PBMC activity upon endosome function inhibition (chloroquine) and TLR2 blockade (T2.5) followed by TLR ligand challenge or bacterial infection.Activity of whole blood culture upon endosome function inhibition (chloroquine) and challenge with TLR ligands, heat‐inactivated (hi), or viable bacteria.Data information: Graphs show mean ± SD; n = 3; *P ≤ 0.05; **P ≤ 0.01; unpaired t‐test; –, unchallenged; P3C, Pam3 CSK 4; n.d., not detected; triangles, decreasing doses of exponentially growing bacteria gentamicin‐treated 1 h post‐infection.CC BY-NC-ND · PubMed Central
Figure EV4 Phylogenetic tree illustrating TLR13 and/or TLR8 expression by Coelomata species including human and mouse Species‐specific expression of either TLR13 exclusively (green species name), both TLR13 and TLR8 (blue), or TLR8 exclusively (orange). Additional symbols behind the species names indicate if expression of at least one of the two TLRs is uncertain and specific information on gene appearance and protein sequence annotation as found. Separated by a slash, the first mark specifies TLR8 expression, while the second one specifies TLR13 expression (+, expression certain: annotation as protein alone or additional gene annotation in genome sequence; †, expression of functional protein due to potential pseudogene carriage not obligatory: no protein annotation while gene is being annotated in genome sequence; –, expression unlikely: no protein annotation and not annotated in genome or the latter not analyzed due to unavailability of assembled genome).
Figure EV4 Phylogenetic tree illustrating TLR13 and/or TLR8 expression by Coelomata species including human and mouse Species‐specific expression of either TLR13 exclusively (green species name), both TLR13 and TLR8 (blue), or TLR8 exclusively (orange). Additional symbols behind the species names indicate if expression of at least one of the two TLRs is uncertain and specific information on gene appearance and protein sequence annotation as found. Separated by a slash, the first mark specifies TLR8 expression, while the second one specifies TLR13 expression (+, expression certain: annotation as protein alone or additional gene annotation in genome sequence; †, expression of functional protein due to potential pseudogene carriage not obligatory: no protein annotation while gene is being annotated in genome sequence; –, expression unlikely: no protein annotation and not annotated in genome or the latter not analyzed due to unavailability of assembled genome).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 99

Metadata

Authors
Krüger, A., Oldenburg, M., Chebrolu, C., Beisser, D., Kolter, J., Sigmund, A. M., Steinmann, J., Schäfer, S., Hochrein, H., Rahmann, S., Wagner, H., Henneke, P., Hornung, V., Buer, J., & Kirschning, C. J.
Affiliations
  • University of Duisburg-Essen (DE)
  • University Medical Center Freiburg (DE)
  • Bavarian Nordic (Germany) (DE)
  • Technical University of Munich (DE)
  • University of Bonn (DE)
Corresponding author
Kirschning, Carsten J
Venue
The EMBO Reports
Published
2015-11-06
Volume
16
Issue
12
Pages
1656-1663
ISSN
  • 1469-221X (ISSN-L)
  • 1469-3178
OpenAlex
W2144246130
Cited by
99
References
34
Citations by year
2026: 9 · 2025: 9 · 2024: 9 · 2023: 9 · 2022: 8 · 2021: 6 · 2020: 11 · 2019: 7 · 2018: 10 · 2017: 13 · 2016: 8
FWCI
5.10
Type
journal article
Language
en
Open access
Licence
Locations
  • EMBO Reports (publishedVersion, other-oa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
Funders
German Research Foundation (TRR60, GK1949)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
Keywords
TLR8, TLR13, TLR2, oligoribonucleotides, mitochondrial RNA, bacterial RNA, 23S rRNA, 16S rRNA, MyD88 signaling, UNC93B1, THP-1 cells, peripheral blood mononuclear cells, sepsis, Gram-positive bacteria, innate immunity
MeSH terms
RNA, Mitochondrial, Animals, Escherichia coli, Humans, Leukocytes, Mononuclear, Oligoribonucleotides, RNA, RNA, Bacterial, RNA, Ribosomal, 16S, Staphylococcus aureus, Cell Line, Tumor, Toll-Like Receptor 8, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human TLR8 senses UR/URR motifs in bacterial and mitochondrial RNA. https://app.cochat.ai/papers/10.15252/embr.201540861
The paper
Krüger, A., Oldenburg, M., Chebrolu, C., Beisser, D., Kolter, J., Sigmund, A. M., Steinmann, J., Schäfer, S., Hochrein, H., Rahmann, S., Wagner, H., Henneke, P., Hornung, V., Buer, J., & Kirschning, C. J. (2015). Human TLR8 senses UR/URR motifs in bacterial and mitochondrial RNA. The EMBO Reports. https://doi.org/10.15252/embr.201540861

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.